Mental Health Clinics in Birmingham, MI Accepting Medicare
84 Mental Health Clinics found. Showing 81 - 84
 Craig Counseling Services, P.l.l.c. Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 630 N. Old Woodward Ave., Suite 303, Birmingham, MI 48009 Phone: 248-321-1212 Fax: 248-928-2051 |
Self-care Center Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 640 N Old Woodward Ave, 301, Birmingham, MI 48009 Phone: 248-564-3402 Fax: 248-792-5464 |
Dr Laura Lehmann, Pllc Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 500 Lewis Ct, Birmingham, MI 48009 Phone: 248-270-2030 Fax: 248-282-5335 |
Shimmel Counseling Agency, Llc Clinic - Adult Mental Health Medicare: Not Enrolled in Medicare Practice Location: 950 E Maple Rd Ste 122, Birmingham, MI 48009 Phone: 248-821-2981 |
News Archive
Reduced heparin dose lowers bleeding risk after PCI without increasing risk of ischaemic complications
With both bleeding und thrombotic complications having a negative effect on PCI outcomes, increasing efforts have been made to improve PCI anticoagulation regimens. Although unfractionated heparin has been the standard anti-thrombotic agent in interventional cardiology for decades, there is still no solid evidence from large clinical trials to guide its dosing during PCI.
EORTC trial evaluates effectiveness of pembrolizumab in patients with high-risk stage III melanoma
A recently opened double- blind phase III EORTC trial 1325 will prospectively assess whether post-operative adjuvant therapy with pembrolizumab, an anti-PD-1 monoclonal antibody, improves recurrence-free survival as compared to placebo in patients with high-risk stage III melanoma.
Laser autofocus option added to BioTek's Cytation Cell Imaging Multi-Mode Readers
BioTek's award-winning Cytation Cell Imaging Multi-Mode Readers now have an option for laser autofocus, along with the current image-based autofocus method.
FDA issues the first marketing denial orders for about 55,000 flavored ENDS products
Today, the U.S. Food and Drug Administration issued the first marketing denial orders (MDOs) for electronic nicotine delivery system (ENDS) products after determining the applications for about 55,000 flavored ENDS products from three applicants lacked sufficient evidence that they have a benefit to adult smokers sufficient to overcome the public health threat posed by the well-documented, alarming levels of youth use of such products.
› Verified 7 days ago